logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Opioid Agonist/Antagonist class drugs

    FiltersReset Filters
    4 results
    • butorphanol tartrate

      (Butorphanol Tartrate)
      Apotex Corp.
      Usage: Butorphanol tartrate nasal spray is indicated for managing severe pain that requires opioid analgesics when alternative treatments are insufficient. It should be reserved for patients who cannot tolerate or achieve adequate relief from non-opioid options, and long-term use is not recommended unless necessary.
    • butorphanol tartrate

      (Butorphanol Tartrate)
      Hospira, Inc.
      Usage: Butorphanol Tartrate Injection is indicated as a preoperative or pre-anesthetic medication, a supplement to balanced anesthesia, for pain relief during labor, and for managing severe pain that inadequately responds to alternative treatments. It is reserved for patients with limited or ineffective non-opioid analgesics.
    • butorphanol tartrate

      (Butorphanol Tartrate)
      Hikma Pharmaceuticals USA Inc.
      Usage: Butorphanol Tartrate Nasal Spray is indicated for managing severe pain requiring opioid analgesics when alternative treatments are inadequate. It should be used with caution due to risks of addiction, abuse, and misuse, and only when other pain relief options have failed or are intolerable.
    • nalbuphine hydrochloride

      (NALBUPHINE HYDROCHLORIDE)
      Hospira, Inc.
      Usage: Nalbuphine Hydrochloride Injection is indicated for managing severe pain requiring opioid analgesics when alternative treatments are insufficient. It may also be used as a supplement in balanced anesthesia, for preoperative and postoperative pain relief, and for obstetrical analgesia during labor and delivery.